<p>Russia expects to register a second potential vaccine against Covid-19 by October 15, the TASS news agency cited Russian consumer safety watchdog Rospotrebnadzor as saying on Tuesday.</p>.<p>The vaccine has been developed by Siberia's Vector Institute, which completed early-stage human trials of the vaccine last week.</p>.<p><strong><a href="https://www.deccanherald.com/national/coronavirus-news-live-updates-india-world-Covid-19-vaccine-karnataka-maharashtra-tamil-nadu-delhi-kerala-gujarat-west-bengal-bengaluru-mumbai-chennai-kolkata-deaths-recoveries-AstraZeneca-Oxford-891129.html" target="_blank">For live updates on the coronavirus outbreak, click here</a></strong></p>.<p>Russia registered its first vaccine candidate, developed by Moscow's Gamaleya Institute, in August. Late-stage trials, involving at least 40,000 people, are ongoing. </p>
<p>Russia expects to register a second potential vaccine against Covid-19 by October 15, the TASS news agency cited Russian consumer safety watchdog Rospotrebnadzor as saying on Tuesday.</p>.<p>The vaccine has been developed by Siberia's Vector Institute, which completed early-stage human trials of the vaccine last week.</p>.<p><strong><a href="https://www.deccanherald.com/national/coronavirus-news-live-updates-india-world-Covid-19-vaccine-karnataka-maharashtra-tamil-nadu-delhi-kerala-gujarat-west-bengal-bengaluru-mumbai-chennai-kolkata-deaths-recoveries-AstraZeneca-Oxford-891129.html" target="_blank">For live updates on the coronavirus outbreak, click here</a></strong></p>.<p>Russia registered its first vaccine candidate, developed by Moscow's Gamaleya Institute, in August. Late-stage trials, involving at least 40,000 people, are ongoing. </p>